Venus Medtech (Hangzhou) Inc. (HKG:2500)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.130
+0.040 (3.67%)
Jul 31, 2026, 4:08 PM HKT

Venus Medtech (Hangzhou) Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
306.79306.79470.83491.37406.46415.86
Revenue Growth
-28.19%-34.84%-4.18%20.89%-2.26%50.65%
Gross Profit
211.83211.83367.75389.21314324.34
Operating Income
-345.32-345.32-365.62-588.55-672.19-281.83
Net Income
-407.69-407.69-714.31-703.75-1,058-373.64
Earnings Per Share
-0.93-0.93-1.63-1.61-2.42-0.85
EPS Growth
------

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Mainland China
208.46208.46388.33418.7354.57405.35
Other countries
98.3298.3282.5172.6751.8910.52
Total
306.79306.79470.83491.37406.46415.86

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
263.77263.77305.7781.641,8792,955
Total Debt
216.34216.34369.09826.19899.6470.78
Net Cash (Debt)
47.4347.43-63.39-44.55979.792,884
Net Cash Growth
-----66.03%7.81%
Net Cash Per Share
0.110.11-0.14-0.102.246.58

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-321.35-321.3523.74-610.02-729.46-456.92
Capital Expenditures
-10.76-10.76-33.92-260.64-169.98-82.07
Free Cash Flow
-332.11-332.11-10.18-870.66-899.44-538.99
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
69.05%69.05%78.11%79.21%77.25%77.99%
Operating Margin
-112.56%-112.56%-77.65%-119.78%-165.38%-67.77%
Pretax Margin
-131.98%-131.98%-157.32%-149.65%-284.49%-90.79%
Profit Margin
-132.89%-132.89%-151.71%-143.22%-260.22%-89.85%
FCF Margin
-108.25%-108.25%-2.16%-177.19%-221.28%-129.61%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
108.1593.6593.6593.6593.6593.65
PS Ratio
1.453.054.914.5513.5925.39